PHARMACOKINETIC STUDY OF THE PHARMACEUTICAL COMPOSITION BASED ON DIINDOLYLMETHANE IN FEMALE PATIENTS WITH ENDOMETRIAL HYPERPLASIA WITHOUT ATYPIA Article Andrianova E., Paltsev M., Kiselev V., Drukh V., Muyzhnek E., Kuznetsov I. Biology and Medicine. AstonJournals. Vol. Vol7. 2015.
DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED MULTICENTER CLINICAL TRIAL (PHASE IIA) ON DIINDOLYLMETHANE'S EFFICACY AND SAFETY IN THE TREATMENT OF CIN: IMPLICATIONS FOR CERVICAL CANCER PREVENTION Article Ashrafian L., Suhikh G., Kiselev V., Paltsev M., Drukh V., Kuznetsov I., Muyzhnek E., Apolikhina I., Andrianova E. EPMA Journal. BioMed Central Ltd.. Vol. Vol625. 2015.
STUDY TO ASSESS SAFETY AND TOLERABILITY OF THE PHARMACEUTICAL COMPOSITION BASED ON DIINDOLYLMETHANE IN PATIENTS WITH ENDOMETRIAL HYPERPLASIA WITHOUT ATYPIA Article Andrianova E., Paltsev M., Kiselev V., Drukh V., Muyzhnek E., Kuznetsov I. Biology and Medicine. AstonJournals. Vol. Vol7. 2015.